Genetic characterisation of Norovirus strains in outpatient children from rural communities of Vhembe district / South Africa, 2014-2015 by Kabue, Jean Pierre et al.
Contents lists available at ScienceDirect
Journal of Clinical Virology
journal homepage: www.elsevier.com/locate/jcv
Genetic characterisation of Norovirus strains in outpatient children from
rural communities of Vhembe district/South Africa, 2014–2015
Jean Pierre Kabuea,⁎, Emma Meaderb, Paul R. Hunterb,c, Natasha Potgietera,d
a Department of Microbiology, School of Mathematical and Natural Sciences, University of Venda, Thohoyandou, South Africa
b School of Medicine, Health Policy and Practice, University of East Anglia, Norwich, UK
c Department of Environmental Health, Tshwane University of Technology, Pretoria, South Africa
d Dean, School of Mathematical and Natural Sciences, University of Venda, Thohoyandou, South Africa
A R T I C L E I N F O
Keywords:
Norovirus
Genetic diversity
GII.4 variants
Rural communities
Outpatient children
A B S T R A C T
Background: Norovirus (NoV) is now the most common cause of both outbreaks and sporadic non-bacterial
gastroenteritis worldwide. However, data supporting the role of NoV in diarrheal disease are limited in the
African continent.
Objectives: This study investigates the distribution of NoV genotypes circulating in outpatient children from rural
communities of Vhembe district/South Africa.
Study design: Stool specimens were collected from children under ﬁve years of age with diarrhea, and controls
without diarrhea, between July 2014 and April 2015. NoV-positive samples, detected previously by Realtime
PCR, were analysed using conventional RT-PCR targeting the partial capsid and polymerase genes. Nucleotide
sequencing methods were performed to genotype the strains.
Results: The sequence analyses demonstrated multiple NoV genotypes including GI.4 (13.8%), GI.5 (6.9%),
GII.14 (6.9%), GII.4 (31%), GII.6 (3.4%), GII.P15 (3.4%), GII.P21 (3.4%) and GII.Pe (31%). The most prevalent
NoV genotypes were GII.4 Sydney 2012 variants (n = 7) among the capsid genotypes, GII.Pe (n = 9) among the
polymerase genotypes and GII.Pe/GII.4 Sydney 2012 (n = 8) putative recombinants among the RdRp/Capsid
genotypes. Two unassigned GII.4 variants were found.
Conclusions: The ﬁndings highlighted NoV genetic diversity and revealed continuous pandemic spread and
predominance of GII.Pe/GII.4 Sydney 2012, indicative of increased NoV activity. An unusual RdRp genotype
GII.P15 and two unassigned GII.4 variants were also identiﬁed from rural settings of the Vhembe district/South
Africa. NoV surveillance is warranted to help to inform investigations into NoV evolution and disease burden,
and to support on-going vaccine development programmes.
1. Background
Diarrhea is more prevalent in the developing world [1,2], due
mainly to the lack of safe drinking water and poor or non-existent sa-
nitation infrastructure and hygiene practices. There are a billion more
people without improved sanitation in rural areas than in urban areas
[3]. Subsequently, a large proportion of rural communities are exposed
to bacterial, viral and parasitic pathogens [2,4].
NoVs are single stranded, non-enveloped, positive-sensed RNA
viruses [5,6] and the genus includes more than 35 diﬀerent strains
which are divided into seven genogroups. Each genogroup is further
subdivided into genoclusters based on sequence similarity and phylo-
genetic analysis [7–10]. The genetic diversity of the NoV genomes is a
result of point mutations [11] and recombination between strains [12].
Based on amino acid variations in the major structural protein (VP1)
[7,10], the seven genogroups of NoV are subdivided into 41 genotypes
with 9 genotypes in GI, 22 in GII, 3 in GIII, 2 each in GIV-VI and one in
GVII [7,10,13–15].
Based on the RNA-dependent RNA polymerase (RdRp) and capsid
gene sequences, 31 polymerase genotypes and 22 capsid genotypes of
GII NoV have been determined to date [16]. Of these, GII.4 is pre-
dominant, causing at least six epidemics of gastroenteritis worldwide
over the past 20 years (1995–1996, 2002, 2004, 2006, 2009, and 2012)
with the emergence and rapid global spread of viral variants [17]. The
emergence of novel NoV GII.4 variants is likely to be driven by genetic
recombination [18].
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Currently there is scarcity of data on the NoV genotypes circulating
in rural communities of Africa [19] and the impact of inadequate sa-
nitation on the genetic diversity, disease burden and transmission of
circulating NoV strains.
2. Objectives
This study aimed to provide genetic characteristics and distribution
of NoV genotypes circulating in outpatient children with and without
diarrhea from rural communities of Vhembe district/South Africa.
3. Study design
3.1. Sample collection, RNA extraction and NoV detection
Between July 2014 and April 2015, a cross-sectional study was
performed involving out-patient children under 5 years of age with and
without diarrhoea, attending Primary Health Care (PHC) centres.
Diarrhea was deﬁned as three or more episodes of watery stool in the
previous 24 h [20]. The study protocol and consent procedures were
approved by the ethics committees of the Department of Health in the
Limpopo Province (Ref. 4/2/2) and University of Venda (Ref. SMNS/
13/MBY/0212). Written, informed consent was given by the parent or
guardian of the child before stool sample collection. Stool samples were
randomly collected at diﬀerent clinics located in the rural communities
of Vhembe district in Limpopo Province, South Africa and analysed at
the molecular laboratory of the department of Microbiology, University
of Venda. A total of 40 clinics were selected as sampling sites for this
study. Demographic and clinical data from this study have been pre-
viously reported [21].
NoV RNA extraction using the Boom method and NoV detection
using the one-step RIDA© GENE NOROVIRUS I & II real-time RT-PCR
assay performed in this study were previously published [21].
3.2. NoV RT-PCR
Fifty RNA extracts that tested NoV positive by One-step Real-time
PCR [21] were randomly selected and subjected to RT-PCR ampliﬁca-
tion for the purpose of nucleotide sequencing. The primers used for RT-
PCR are listed in Table 1.
One step Ahead RT-PCR (QIAGEN) was performed using oligonu-
cleotide primer sets GISKF/GISKR to amplify 330 bp of GI capsid
fragment, GIISKF/GIISKR for 344 bp of a GII capsid fragment as pre-
viously described [22] or designed WGS 9F/WGS 9R primer pair to
amplify a 751 bp product in those samples that did not yield products
with the GIISK primers. Brieﬂy a 10% diluted 5 μl of RNA extract was
transcribed into cDNA for 10 min at 50 °C followed by heat inactivation
of reverse transcriptase at 95 °C for 5 min, and then ampliﬁed using
0.5 μM of each oligonucleotide primer in a ﬁnal reaction volume of
25 μl. PCR was carried out for 40 cycles using the following thermo-
cycling conditions: denaturation for 10 s at 95 °C, annealing for 10 s at
56 °C (GII SK primers) or 50 °C (GISK primers or WGS 9 primers) and
extension for 10 s at 72 °C followed by a ﬁnal extension for 10 min at
72 °C.
Primers set JV12/JV13 were used to amplify 326 bp of the RdRp
fragment as previously described [23]. PCR conditions for polymerase
gene fragment ampliﬁcation consisted of denaturation for 10 s at 95 °C,
annealing for 10 s at 50 °C and extension for 10 S at 72 °C and a ﬁnal
extension for 10 min at 72 °C.
The amplicons were separated by electrophoresis on a 2% agarose
gel stained with ethidium bromide and speciﬁc sized bands visualised
using a UV light transilluminator. SimplyLoad 100 bp DNA ladder
(Lonza) was used for every electrophoretic gel.
3.3. Genotyping and phylogenetic analysis of NoV strains
The PCR products of the ampliﬁed fragments were directly puriﬁed
with a master mix of ExoSAP (Nucleics, Australia). Using the same
speciﬁc primers, the Sanger sequencing was performed on the ABI
3500XL Genetic Analyzer POP7™ (Thermo-Scientiﬁc). The raw se-
quence reads were edited with Finch TV v1.4 (Geospiza, Seattle, USA).
The Nucleotide sequences of NoV obtained from this study were
compared with those of the reference strains available in the NCBI
GenBank using BLAST tool available at http://www.ncbi.nlm.nih.gov/
blast and were then analysed for their genotypes using Noronet typing
tools [24] available at http://www.rivm.nlm/norovirus/typingtool
before subjecting to phylogenetic tree construction using MEGA 7
software [25]. The reference strains from Genbank were randomly se-
lected among the Blast hits with>80% similarities on the query se-
quence of the NoV strains identiﬁed from this study. The neighbor-
joining method [26] was used to build the phylogenetic tree and the
reliability of the diﬀerent phylogenetic groupings was evaluated by
bootstrap analysis (1000 replicates) [27]. The evolutionary distances
were computed using the p-distance method [28].
Clustal Omega (http://www.ebi.ac.uk/Tools/msa/clustalo/) was
used to generate percent identity matrix of aligned sequences that were
GII.4 not assigned.
The nucleotide sequences of NoV strains obtained from this in-
vestigation were submitted to NCBI GenBank under the following ac-
cession numbers: KY012277-KY012287 and KY548495-KY548501 for
the capsid genotypes, KY012288-KY012295 and KY548502-KY548504
for the RdRp genotypes.
4. Results
4.1. Sequence analysis of capsid and polymerase region fragments
Out of 50 NoV positive samples subjected to RT-PCR ampliﬁcation,
Twenty-one specimens (42%, 21/50) were successfully ampliﬁed and
sequenced for capsid or polymerase fragment region. Failure to obtain
amplicons or good quality sequence could be due to the low viral load
or RNA degradation in the samples.
At least nine genotypes were identiﬁed among twenty-nine nu-
cleotide sequences of GI (n = 6) and GII (n = 23) NoV strains obtained
Table 1
Primers used for Norovirus genotyping in this study.
Primers Sequence(5′-3′) Polarity Genotype Target Size(bp) Nucleotide position Reference
G1SKF CTGCCCGAATTYGTAAATGA F GI NoV Capsid 330 bp 5342 Kojima et al. [22]
G1SKR CCAACCCARCCATTRTACA R GI NoV Capsid 5671 Kojima et al. [22]
G2SKF CNTGGGAGGGCGATCGCAA F GII NoV Capsid 344 bp 5058 Kojima et al. [22]
G2SKR CCRCCNGCATRHCCRTTRTACAT R GII NoV Capsid 5401 Kojima et al. [22]
JV12 ATACCACTATGATGCAGATTA F GI and GII NoV RdRp 326 bp 4552 Vinje et al. [23]
JV13 TCATCATCACCATAGAAAGAG R GI and GII NoV RdRp 4878 Vinje et al. [23]
WGS 9F CACCCACAGTTGAGTCAAGAAC F GII NoV Capsid 751 bp 5734a
WGS 9R GGAGCTGCCTCTTGGTAGA R GII NoV Capsid 6484a
a Accession number of reference strain from Genbank used to design the primer WGS9F/9R: JN595867.1.
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(Table 2) comprising:
1) GI.4, GI.5, GII.14, GII.6, GII.4 Sydney 2012 variant and GII.4 not
assigned variant for the sequences with only the capsid fragment
available.
2) GII.Pe, GII.P15 and GII.P21 for the sequences with only the RdRp
fragment gene available.
3) GII.Pe/GII.4 Sydney 2012 variant for the sequences with both
RdRp/Capsid fragments gene available.
As shown on Table 2, GII.4 Sydney 2012 variants (7/17, 41.2%)
were predominant followed by GI.4 (4/17, 23.5%) among capsid gen-
otypes. GII.Pe (9/11, 81.8%) was the predominant polymerase
genotype and GII.Pe/GII.4 Sydney 2012 variants (8/8, 100%) were the
predominant RdRp/Capsid genotypes.
4.2. Phylogenetic analyses of NoV GI, GII capsid genotypes and GII
polymerase genotypes
Representative phylogenetic trees based on partial nucleotide se-
quences of RdRp and capsid genes were generated by the neighbor-
joining method (Fig. 1 for the 344 bp of a GII capsid fragment; Fig. 2 for
the 751 bp of a GII capsid fragment; Fig. 3 for 326 bp of the RdRp
fragment and Fig. 4 for the 330 bp of GI capsid fragment).
The phylogenetic analyses in Fig. 1 revealed sequences KY012282
and KY012284, genotyped as GII.4 not assigned variants (Table 2),
were closely related to GII.4 Sydney 2012 variant reference strains.
Clustal analyses showed that sequence KY012282 was 97–99% similar
to the reference strains KR904507.1 (South Africa), KF060126.1 (New
Zealand), KF008241.1 (Paris), HQ003277.1 (Russia) and KY012284
was 95–98% similar to KX354140.1 (USA), KP335066.1 (China),
KF060080.1 (Australia) and HQ003277.1 (Russia) reference strains
(Supplement A).
With note, the phylogenetic analyses in Fig. 3 revealed that the
unusual genotype GIIP15, identiﬁed in this study, has a common an-
cestor with Hiroshima/66/1110/06/JP accession number AB360387.1
clustering with other GII strains (KJ710248.1 and FM210353.1). This
GIIP15 strain from Japan was previously reported as GII/untypeable
recombinant strain implicated in a gastroenteritis outbreak [29].
Diﬀering RdRp and Capsid genotypes, suggesting putative re-
combinant strains, were found in 8 NoV positive specimens including
GII.Pe/GII.4 Sydney 2012 variant (n = 6) and GII.Pe/GII.4 not assigned
Table 2
Genotype distribution of identiﬁed NoV strains in stool specimens between July 2014 and
April 2015 in Rural communities of Vhembe district/South Africa.
Genogroup Genotype Genotype Genotype
RdRp n (%) Capsid n (%) RdRp/Capsid n (%)
GI GI.4 4 (22.2)
GI.5 2 (11.1)
GII GII.Pe 9 (81.8) GII.14 2 (11.1) GII.Pe/GII.4 8(100)
GII.P15 1 (9.1) GII.4 9 (50)a
GII.P21 1 (9.1) GII.6 1 (5.6)
Total 11 18 8
a Including GII.4 Sydney 2012(n = 7, 41.2%) variant and GII.4 not assigned variant
(n = 2, 11.7%).
Fig. 1. Phylogenetic tree based on 344-nucleotide sequence of the NoV GII capsid gene fragment. The Neighbor-Joining tree of the GII capsid strains circulating between July 2014 and
April 2015 in the rural communities of Vhembe district/South Africa. Round Black dots indicated the GII.4 capsid genotypes, squared dots for GII.14 capsid genotypes and triangle dots
indicated GII.6 genotype from this study. Only bootstrap values greater than 70% are shown.Thirty-three references strains of NoV were selected from Genbank and used to build this
phylogenetic tree.
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(n = 2). Further conﬁrmatory analysis is currently pending.
5. Discussion
This study aimed to investigate the genetic characteristics of NoV
strains circulating in rural communities of Vhembe district, South
Africa, between July 2014 and April
2015, and represents one of the few studies on NoV-associated
gastroenteritis from outpatients in rural settings of the African con-
tinent. A combined analysis of partial ORF1 and ORF2 regions that
allow diﬀerentiation of RdRp polymerase genotypes, capsid genotypes
and RdRp/Capsid genotypes of NoV was performed in this study.
Multiple NoV genotypes (Table 2) found in the current study high-
lighted the diverse range of NoV genotypes circulating in rural com-
munities of Vhembe district, South Africa.
The study ﬁndings showed the predominance of the GII.4 Sydney
2012 variant, which has been widely associated with an increased NoV
activity and outbreaks across the globe [30–33]. Mans et al., 2016 re-
ported GII.4 Sydney 2012 variants from hospitalised children in some
regions of South Africa between 2009 and 2013 [34]. Our ﬁndings
indicate the continuous pandemic spread of GII.4 Sydney 2012 variants
between 2014 and 2015 in rural South Africa.
GII.Pe, which was the predominant polymerase genotype in the
current study, has been involved in NoV outbreaks in several countries
including Brazil [35], South Africa [34], Korea [36], China [37], Aus-
tralia [38] and Japan [39]. Interestingly, the GII.Pe strains (Fig. 3)
identiﬁed during this study period are genetically far less related to the
GII.Pe genotypes previously reported in South Africa (KR904759.1 and
KR904767.1) between 2009 and 2013. These ﬁndings indicate the
continuous evolution of NoVs in these rural communities of South
Africa, possibly via accumulation of mutations and/or recombination
[40] and support the need for surveillance of NoV genotypes. GII.Pe has
been frequently reported in combination with capsid genotypes
including GII.4 Sydney 2012 variant, GII.3 and GII.12 [38,41–43].
Bruggink et al., 2014 speculated that GII.Pe is considered as an ob-
ligatory recombinant in that no single GII.Pe genotype ever been re-
ported [38]. This corroborates with our ﬁndings, where eight out of
nine GII.Pe genotypes identiﬁed were in combination with GII.4 Sydney
2012 variant (Table 2).
GII.Pe/GII.4 Sydney variant recombinants emerged for the ﬁrst time
in Australia and became a pandemic NoV GII.4 variant [31]. GII.Pe/
GII.4 Sydney variants are recombinants of GII.Pe polymerase and GII.4
capsid gene variant that have the common ancestor with Apeldoorn
2008 and New Orleans 2009 GII.4 variants [31]. The GII.Pe/GII.4
Sydney 2012 variant (n = 8) predominantly reported in this study have
been considered as putative recombinants, although further conﬁrma-
tion needs to be done.
GI.4 (n = 4) and GI.5 (n = 2) capsid genotypes reported in this
study have been previously found in waterborne NoV outbreaks and
environmental sources in several countries including Italy, Thailand,
Korea, South Africa and Sweden [44–49]. The presence of these GI
capsid genotypes in clinical specimens from children in rural commu-
nities with poor hygiene practice and polluted environments [50] in-
dicate water-borne NoV transmission despite the absence of direct
molecular evidence of NoV contamination of water in this study. En-
vironmental NoV studies are warranted to ascertain the environmental
transmission route of NoV in the study area.
Other globally distributed genotypes identiﬁed in this study include:
• GII.14 genotypes ﬁrst detected in 1999 in China [51] and later
emerged as major genotype in Spain [52] and Japan [53]. GII.14
strains have been weakly associated with sporadic gastroenteritis in
Brazil [54], in China [55] and several countries of Africa [56].
• GII.6, which has been associated with sporadic gastroenteritis and
outbreaks in Japan [57], China [58], USA [59], Brazil [60], Finland
[42] and numerous African countries [56];
Fig. 2. Phylogenetic tree based on 751-nucleotide sequence of the NoV GII capsid gene fragment. The Neighbor-Joining tree of the GII.4 capsid strains circulating between July 2014 and
April 2015 in the rural communities of Vhembe district/South Africa. Round Black dots indicated the GII.4 capsid genotypes from this study. Only bootstrap values greater than 70% are
shown. Twenty representative references strains of NoV were selected from Genbank and used to build this phylogenetic tree.
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• GII.P21, which was previously reported in Denmark [61], Austria
[62], India [63], Slovenia [64], Brazil [65] and some countries of
Africa [56].
The rare GII.P15 polymerase genotype has also been found in this
study and to our knowledge this is the ﬁrst report of this unusual
genotype in the African continent. GII.P15 has previously been identi-
ﬁed as an intergenogroup (GII.P15/GVI) recombinant genotype (Mex
7076/99) in Japan [66] and was implicated in sporadic gastroenteritis
cases. In studies of recombinant NoV implicated in gastroenteritis in
Hiroshima Prefecture/Japan, Fukuda et al. [29] reported GII.P15
(GQ856474) as GII/untypeable strain (Hiroshima/66/1110/06/JP),
which shares a common ancestor with the GII.P15 identiﬁed in this
study (Fig. 3).
Jin et al. [67] found GII.P15 strains in outpatients with sporadic
gastroenteritis in China and classiﬁed them simply as GII genogroup
since a genotype could not be assigned based on the partial polymerase
sequence. Recently Fumian et al. [65] reported the presence of GIIP15/
GII15 genotyped as a non-recombinant form in a NoV outbreak in
Southern Brazil. The existence of numerous GII.4 recombinant variants
circulating with the uncommon genotypes ensures enormous potential
for novel viral recombination [68]. Continuous monitoring of the
strains distribution in the population will allow the identiﬁcation of
epidemic-causing strains in real-time.
This study has some limitations. First, the NoV genotyping of iso-
lates was only performed for selected number of NoV-positive samples
because of the cost limit. However we have identiﬁed multiple geno-
types within the selected sampling set. In addition, we were not able to
complete the recombination analyses to conﬁrm the recombinant gen-
otypes, given that the sequences used for our NoV characterisation did
not span the entire region of the ORF1-ORF2 junction where most of
NoV recombinant events are detected.
This report describes the NoV genetic diversity detected from chil-
dren under ﬁve with diarrhea, attending PHC centres in rural com-
munities. We previously reported a 41.1% prevalence of NoV in this
study area [21] demonstrating frequent exposure of young children to
enteric pathogens. Considering that all the children with gastroenteritis
disease may not present to any healthcare facilities, what we have re-
ported could be the tip of iceberg. The ﬁnding of high levels of NoV
prevalence rate in this study area and the predominance of GII.4 Sydney
2012 genotype observed in the current report, which has been widely
associated with increased NoV outbreaks [31], suggest that there was
increased NoV activity in the study region. This has not been described
before since there is no surveillance of NoV in South Africa, and this
ﬁnding may also be the case throughout Africa. Detection and char-
acterisation of NoV genotypes in Africa may be useful to conﬁrm the
role of the NoV in diarrheal disease across the continent and assist the
on-going NoV vaccine development. Further eﬀorts should be deployed
to promptly investigate epidemic cases of NoV. This requires the im-
plementation of systematic surveillance of NoV associated gastro-
enteritis in African continent.
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